» Articles » PMID: 19533247

Both Fibrous Capsule Formation and Extracapsular Penetration Are Powerful Predictors of Poor Survival in Human Hepatocellular Carcinoma: a Histological Assessment of 365 Patients in Japan

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2009 Jun 18
PMID 19533247
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A new definition of infiltration to the capsule (fc-inf) has been proposed as a novel marker for predicting the prognosis of 88 patients with hepatocellular carcinoma (HCC). The current aim was to present evidence to develop the fibrous capsule and fc-inf, from the Japanese histological findings for HCC, and to validate their biological significances and predictive power of survival in a large series.

Methods: A total of 365 HCCs were divided into HCCs without the fibrous capsule (NC type; n = 135) and HCCs with the fibrous capsule (FC type; n = 230). Then, FC type was subclassified into two types: extracapsular infiltrating (EC) type (n = 125), in which cancer cells penetrated outside the fibrous capsule, and intracapsular (IC) type (n = 105), in which the infiltrating cancer cells stayed inside the fibrous capsule.

Results: The proportion of less histological differentiation and portal venous invasion was higher in FC type than in NC type. The fibrous capsule came to be observed according to the increase of tumor size (P < 0.0001). FC type had significantly poorer outcome for overall survival than NC type (P = 0.0022). EC type showed more intrahepatic metastasis than IC type. The macroscopic subclassifications were significantly affected the presence of fc-inf. EC type had significantly poorer outcome for disease-free survival than IC type (P = 0.0132) and was an independent prognostic factor for disease-free survival (P = 0.0482).

Conclusions: Fc-inf defined as extracapsular penetration was verified to be a novel marker for predicting prognosis, and presence of fc-inf might be predicted by tumor gross features.

Citing Articles

Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma.

Cheng Y, Chen X, Feng L, Yang Z, Xiao L, Xiang B Cell Discov. 2025; 11(1):1.

PMID: 39870619 PMC: 11772884. DOI: 10.1038/s41421-024-00747-z.


Exploring the MRI and Clinical Features of P53-Mutated Hepatocellular Carcinoma.

Weng J, Xiao Y, Liu J, Liu X, He Y, Wu F J Hepatocell Carcinoma. 2024; 11:1653-1674.

PMID: 39224117 PMC: 11368099. DOI: 10.2147/JHC.S462979.


Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.

Kasuga R, Taniki N, Chu P, Tamura M, Tabuchi T, Yamaguchi A Sci Rep. 2024; 14(1):10896.

PMID: 38740983 PMC: 11091100. DOI: 10.1038/s41598-024-61611-4.


Dual-phenotype hepatocellular carcinoma: correlation of MRI features with other primary hepatocellular carcinoma and differential diagnosis.

Zhang L, Chen J, Lai X, Zhang X, Xu J Front Oncol. 2024; 13:1253873.

PMID: 38273849 PMC: 10808764. DOI: 10.3389/fonc.2023.1253873.


Prognostic Value of Combined Neutrophil-to-Lymphocyte Ratio and Imaging Tumor Capsule in Solitary Hepatocellular Carcinoma Patients after Narrow-Margin Hepatectomy.

Chen D, Mao P, Sun C, Fan X, Zhu Q, Chen Z J Clin Med. 2024; 13(2).

PMID: 38256485 PMC: 10816149. DOI: 10.3390/jcm13020351.